This article focuses on GitLab ( GTLB ) a smaller SaaS company that may interest investors with high-risk tolerances. The article explains what GitLab does, its “special sauce”, operating metrics and evidence that it’s executing well with artificial intelligence. I also focus onDom received his MBA in Management and B.S. Finance (Manhattan College) and was credit trained at New York University. Dom received the Financial Risk Manager (FRM) designation from GARP.Areas of expertise are: Exponential Age & SaaS ...

POSCO Holdings (PKX) has announced a total investment of KRW 922.6 billion (roughly $660 million) to increase capital in its rechargeable battery material subsidiaries, aiming to enhance their competitiveness and strengthen management of its key business areas. At a board meeting, POSCO Holdings approved capital injections into three rechargeable battery material subsidiaries: KRW 525.6 billion for POSCO Future M, KRW 328 billion for POSCO Pilbara Lithium Solution and KRW 69 billion for POSCO GS Eco Materia ...

Prologis ( PLD ) remains one of my favorite REITs to invest in. I like collecting leaders of respective markets in my portfolio and PLD is an absolute giant of the logistic real estate market coveringWelcome to Cash Flow Venue, where dividends do the heavy lifting! Blending my financial chops with the timeless wisdom of value investing (and love for steady income), I’ve built a rock-solid pillar in my financial foundation through dividend investing. I believe it’s one of the most accessible paths to achievi ...

I give a hold rating for The Cheesecake Factory ( CAKE ) , as I think the near-term upside is already priced in. While I’m encouraged by the strong 1Q25 margin performance, steady SSSG, and momentum in new storeI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit economics, reinvestm ...

This week's rally is particularly encouraging for investors who like to invest in small-cap stocks. The Russell 2000 index, widely considered to be the small-cap index, is up about 3.8% for the week. This continues the momentum that’s been building for the last month, in which the index has climbed 15.7%. Small-cap stocks are particularly sensitive to interest rates. Many of these companies rely on debt for their operations, which means, in some cases, it would be harder for companies to absorb higher tarif ...

Exelon Corporation’s (EXC) investment plans should further strengthen its transmission and distribution infrastructure and assist in providing reliable services to its customers. Exelon's initiatives in grid modernization are likely to improve the resilience of its operations. Given its growth opportunities, EXC makes for a solid investment option in the utility sector.Let’s focus on the factors that make this Zacks Rank #2 (Buy) company a strong investment pick at the moment.EXC’s Growth Projections & Surp ...

UNH climbs over 17 Points after the AlertUnitedHealth Group Inc. (UNH) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. Today, at 10:09AM on May 15th, a significant trading signal occurred for UnitedHealth (UNH) as it demonstrated a Power Inflow at a price of $257.20. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market ...

Further acceleration in revenue growth:+250% 1H year-over-year+160% Q2 year-over-yearOperating expenses reduced by 36% Q2 year-over-yearCash balance increases by 54% over Q1 Fiscal 2025 to $4.4MOttawa, Ontario--(Newsfile Corp. - May 16, 2025) - KWESST Micro Systems Inc. (TSXV: KWE) (TSXV: KWE.WT.U) (NASDAQ: KWE) (NASDAQ: KWESW) ("KWESST" or the "Company") is pleased to announce the highlights of its second quarter of fiscal 2025 ("Q2 Fiscal 2025") results. This announcement is a summary only and should be ...

Acquisition is Strong Strategic Fit for BioMarin, Adding INZ-701, a Phase 3 Enzyme Replacement Therapy Being Developed for Treatment of ENPP1 DeficiencyFirst Pivotal Data Readout in Children Expected in Early 2026 with Potential Launch in 2027; Additional Clinical Programs to Expand to Patients of all Ages Potential First-in-Disease Treatment for ENPP1 DeficiencyConference Call and Webcast Scheduled Today at 8:45 a.m. ETSAN RAFAEL, Calif. and BOSTON, May 16, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. ...

It feels as though we are going through one of those periods in life where things change faster than we can keepAnalyst’s Disclosure: I/we have a beneficial long position in the shares of MAIN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Pa ...